Prota Therapeutics Achieves Peanut Allergy Treatment Milestone: Groundbreaking Clinical Trial Data Demonstrates Clinical Remission of Peanut Allergy in Paediatric Patients
- Wednesday, February 9, 2022, 7:12
- PR Newswire
- Add a comment
Groundbreaking New Clinical Trial Data Published in The Lancet Child & Adolescent Health Data shows that 51% of participants achieved sustained unresponsiveness (clinical remission) to peanut after 18 months of treatment Prota Therapeutics announces new round of capital raising for…
About the Author
admin has written 21776 stories on this site.